Stock screener
All disclosures →
EDGAR →
NEO
Conviction 100HealthcareScan · Thu, Sep 24, 2026Neogenomics Inc (NEO) closed at $19.57 (+6.56%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 63, RS Rating 98, -1.7% from its 52-week high, +66.4% year to date. Sector: Healthcare · SERVICES-TESTING LABORATORIES.
NEO$19.57+6.56%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 2.2M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price19.57
Change+6.56%
Gap+2.02%
Rel volume2.22×
Avg volume2.23M
Avg $ vol41.49M
SMA 2018.34
SMA 5016.69
SMA 20012.12
Price vs 50+17.20%
Price vs 200+61.42%
MA stackbullish
50/200 cross—
Supertrendup · 17.28
RSI (14)63
MACD hist0.00
MACD crossbull · 0d
Stoch %K / %D85 / 65
ADX (14)47
+DI / −DI29 / 13
RSI divergence—
MACD divergence—
ATR %4.30%
ADR %4.75%
52w high19.91
52w low7.19
From 52w high-1.73%
Above 52w low+172.11%
New 52w highNo
SqueezeOff
Bollinger width18.80%
%B0.86
Donchian pos84.78%
Donchian high20.05
Donchian low16.87
AVWAP (52w high)19.08
vs AVWAP high+2.53%
AVWAP (52w low)12.98
vs AVWAP low+50.77%
OBV trendUp
Chaikin MF (20)0.01
Today vs 20d2.22×
Avg vol (14d)2.2M
Avg vol (20d)2.23M
Avg $ vol (20d)41.49M
Market cap2.51B
RS Rating98 / 99
RS 3m (vs SPY)+38.01%
RS 6m (vs SPY)+134.98%
RS line new highNo
Trend template8/8
Technical rank96.4
1 week-1.63%
1 month+16.53%
3 months+42.50%
6 months+151.80%
1 year+140.65%
YTD+66.37%
P/E-23.27
P/B3.20
P/S—
P/FCF-115.42
EPS-0.0400
Div yield—
ROE-13.75%
ROA-7.99%
Debt/Eq0.48
Current3.60
EV/EBITDA-30.48
Gross margin—
Net margin—
Rev growth—
EPS growth-37.22%
Price target18.33
Target upside-6.31%
Analyst ratingBuy
Institutional125.07%
Ent. value2.74B
Revenue67.75M
Net income2.24M
Gross profit91.88M
Free cash flow-21.78M
IndustrySERVICES-TESTING LABORATORIES
ExchangeNasdaq
Shares out130.21M
Employees2.5K
ListedThu, Jan 25, 1996
Free float127M
Float %97.8%
Short interest15.76M
Days to cover9.0d
Short volume57.1%
Squeeze score76 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.01 vs −$0.06
Last surprise+83.3% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank96.4 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance19.90
Support15.60
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- NeoGenomics (NASDAQ:NEO) Trading 4.8% Higher - Here's WhyMarketBeat · Thu, Sep 24, 2026
- NeoGenomics, Inc. (NEO) Stock forecastsYahoo Finance Singapore · Thu, Sep 24, 2026
- Neo Performance Materials Inc. (NEO.TO) stock price, news, quote and historyYahoo Finance UK · Thu, Sep 24, 2026
- NeoGenomics stock falls 2.81 percent after Q2 revenue beatAD HOC NEWS · Thu, Sep 24, 2026
- NEO Oct 2026 22.000 put (NEO261016P00022000) Interactive Stock Chart - Yahoo FinanceYahoo! Finance Canada · Wed, Sep 23, 2026
- Precision Oncology Expansion Could Be A Game Changer For NeoGenomics Stocksimplywall.st · Tue, Sep 22, 2026
- Why Is Neo Performance Materials Stock Up 8.20% as European Magnet Production Reaches Commercial Scale? (TSX:NEO)kalkine.ca · Tue, Sep 22, 2026
- Liquidity Mapping Around (NEO) Price Eventsnews.stocktradersdaily.com · Tue, Sep 22, 2026
- 3 Reasons NEO is Risky and 1 Stock to Buy InsteadYahoo Finance · Tue, Sep 22, 2026
- NeoGenomics, Inc. (NEO) Stock Analysis: Strong Buy Ratings Amid 11.2% Revenue GrowthDirectorsTalk Interviews · Tue, Sep 22, 2026
Congress activity
Disclosed STOCK Act trades in NEO · 2 recent
Insider activity
SEC Form 4 transactions in NEO · open-market 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Stone Warren Pres & Chief Operating Officer · Common Stock · 2026-08-21 | Exercise | 28.11K | — | 2026-08-21 | 2026-08-25 |
Stone Warren Pres & Chief Operating Officer · Common Stock · 2026-08-21 | Tax | 11.06K | — | 2026-08-21 | 2026-08-25 |
Stone Warren Pres & Chief Operating Officer · Restricted Stock Unit · 2026-08-21 | Exercise | 28.11K | — | 2026-08-21 | 2026-08-25 |
Aunan Greg D Chief Accounting Officer · Common Stock · 2026-08-04 | Sell | 20K | $321K | 2026-08-04 | 2026-08-06 |
Starrett Carolyn S Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 9.78K | — | 2026-06-23 | 2026-06-25 |
Starrett Carolyn S Director · Restricted Stock Unit · 2026-06-23 | Grant | 14.13K | — | 2026-06-23 | 2026-06-25 |
TETRAULT LYNN A. Director · Stock Option (Right to Buy) · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-03 |
Perez David Brian Director · Stock Option (Right to Buy) · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-03 |
Kelly Michael Aaron Director · Stock Option (Right to Buy) · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-03 |
Gunn Neil Director · Stock Option (Right to Buy) · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in NEO · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.